Growth Factor and Patient-Adapted Use of Plerixafor Is Superior to CY and Growth Factor for Autologous Hematopoietic Stem Cells Mobilization

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2010.170
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Single-Agent Plerixafor Mobilization to Collect Autologous Stem Cells for Use in Gene Therapy for Severe Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Injury-Activated Transforming Growth Factor Β Controls Mobilization of Mesenchymal Stem Cells for Tissue Remodeling

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2012English

Hematopoietic Stem Cell Mobilization With Plerixafor in Sickle Cell Disease

Haematologica
Hematology
2018English

Evaluating the Role and Efficacy of Plerixafor in Rescue Mobilization of Autologous Peripheral Blood Stem Cells

Journal of Hematology And Oncology Research
2015English

The Use of Granulocyte Colony Stimulating Factor After Autologous Hematopoietic Stem Cell Transplantation

Bratislava Medical Journal
2019English

Heparin-Binding Epidermal Growth Factor-Like Growth Factor and Mesenchymal Stem Cells Act Synergistically to Prevent Experimental Necrotizing Enterocolitis

Journal of the American College of Surgeons
Surgery
2012English

Fibroblast Growth Factor Signaling Is Essential for Self-Renewal of Dental Epithelial Stem Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Pleiotropic Effects of Transforming Growth Factor-Β in Hematopoietic Stem-Cell Transplantation

Transplantation
Transplantation
2010English

The Transcription Factor Foxm1 Is Essential for the Quiescence and Maintenance of Hematopoietic Stem Cells

Nature Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy